Targeted Protein Degradation: From Discovery to Development

SLAS and ELRIG are pleased to sponsor an educational networking event at the new Novartis Pavillon science hub.

In the last 20 years, targeted protein degradation (TPD) has evolved from a basic scientific observation, involved in the control of hormone signaling in plants as well as virus survival, to a point where compounds directing TPD are in the clinic for a number of disease indications.

On June 7, Pavillon, the new science hub on the Novartis Basel Campus will open its doors to host a mini-symposium on the subject of TPD. Located in Basel, one of the pharmaceutical capitals of Europe, this event aims to present a series of vignettes describing efforts from discovery to the development of novel compounds directing TPD.

Attendees may participate in the meeting live or virtually from 15:00 - 17:00 CEST. This is a great opportunity to network in the informal and stimulating environment of the new Pavillon!